BREXUCABTAGENE AUTOLEUCEL

BREXUCABTAGENE AUTOLEUCEL was reported 2158 times

BREXUCABTAGENE AUTOLEUCEL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COMPLEMENT FACTOR 2 0.6667
1 IMMUNE EFFECTOR CELL ENCEPHALOPATHY SCORE 4 0.4444
2 MALIGNANT GENITOURINARY TRACT NEOPLASM 12 0.1791
3 MEDULLARY COMPRESSION SYNDROME 2 0.1667
4 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 18 0.1034
5 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 604 0.1019
6 MANTLE CELL LYMPHOMA REFRACTORY 6 0.0909
7 MANTLE CELL LYMPHOMA RECURRENT 36 0.0828
8 LYMPHOCYTE ADOPTIVE THERAPY 22 0.0789
9 ACUTE ERYTHROID LEUKAEMIA 4 0.0635
10 CELL-MEDIATED CYTOTOXICITY 3 0.0588
11 CD19 LYMPHOCYTES INCREASED 1 0.0588
12 IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME 8 0.0530
13 CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE 1 0.0476
14 CYTOKINE RELEASE SYNDROME 938 0.0467
15 ALVEOLAR RHABDOMYOSARCOMA 2 0.0455
16 LEUKAPHERESIS 1 0.0455
17 LISTERAEMIA 1 0.0400
18 ANAL SQUAMOUS CELL CARCINOMA 12 0.0390
19 GENITOURINARY TRACT NEOPLASM 3 0.0361
20 MENINGITIS EOSINOPHILIC 1 0.0333
21 B-CELL APLASIA 8 0.0310
22 HERPES ZOSTER REACTIVATION 8 0.0305
23 LYMPHODEPLETION 1 0.0294
24 MANTLE CELL LYMPHOMA 37 0.0243
25 IGG DEFICIENCY 1 0.0233
26 INFECTIOUS DISEASE CARRIER 1 0.0213
27 INTENSIVE CARE UNIT DELIRIUM 1 0.0208
28 APHERESIS 1 0.0200
29 MASTOID EFFUSION 1 0.0200
30 TRAUMATIC LUMBAR PUNCTURE 1 0.0196
31 GLIONEURONAL TUMOUR 1 0.0185
32 ALANINE AMINOTRANSFERASE 4 0.0181
33 LACK OF CONCOMITANT DRUG EFFECT 1 0.0175
34 TRANSDIFFERENTIATION OF NEOPLASM 1 0.0172
35 HYPOFIBRINOGENAEMIA 17 0.0171
36 BACTEROIDES BACTERAEMIA 1 0.0167
37 MANTLE CELL LYMPHOMA STAGE IV 1 0.0167
38 GRAFT VERSUS HOST DISEASE ORAL 1 0.0156
39 ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY 2 0.0148
40 SCROTAL PAIN 8 0.0148
41 DIVERTICULITIS INTESTINAL PERFORATED 5 0.0140
42 BLOOD BRAIN BARRIER DEFECT 2 0.0132
43 SQUAMOUS CELL CARCINOMA OF SKIN 75 0.0124
44 NEUROTOXICITY 202 0.0115
45 ENTEROVIRUS TEST POSITIVE 2 0.0115
46 ANTITHROMBIN III DEFICIENCY 1 0.0112
47 IMMUNE-MEDIATED ENCEPHALOPATHY 1 0.0112
48 MORAXELLA INFECTION 3 0.0109
49 NATURAL KILLER CELL COUNT DECREASED 1 0.0109
50 VISUAL FIELD TESTS ABNORMAL 1 0.0108
51 HUMAN HERPESVIRUS 6 ENCEPHALITIS 3 0.0106
52 ADENOVIRUS TEST POSITIVE 1 0.0105
53 HAEMOFILTRATION 2 0.0105
54 BK POLYOMAVIRUS TEST POSITIVE 1 0.0104
55 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA 2 0.0103
56 COMPUTERISED TOMOGRAM HEAD ABNORMAL 1 0.0101
57 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 25 0.0097
58 COMPLEMENT FACTOR ABNORMAL 1 0.0093
59 HYPERFERRITINAEMIA 4 0.0093
60 LARYNGEAL SQUAMOUS CELL CARCINOMA 1 0.0093
61 FLUID INTAKE RESTRICTION 1 0.0091
62 TRANSFUSION RELATED COMPLICATION 1 0.0090
63 HYPOGLOBULINAEMIA 1 0.0088
64 GRAFT VERSUS HOST DISEASE IN EYE 2 0.0087
65 ACHROMOBACTER INFECTION 1 0.0083
66 MINIMAL RESIDUAL DISEASE 4 0.0083
67 IMMOBILISATION PROLONGED 1 0.0082
68 MEAN ARTERIAL PRESSURE DECREASED 2 0.0079
69 KLEBSIELLA URINARY TRACT INFECTION 2 0.0075
70 CYTOKINE INCREASED 1 0.0074
71 PNEUMONIA ACINETOBACTER 1 0.0073
72 CYTOKINE STORM 5 0.0073
73 MUCOSAL HYPERTROPHY 1 0.0068
74 ULTRASOUND LIVER ABNORMAL 1 0.0066
75 LEUKAEMIA CUTIS 1 0.0065
76 ALLOGENIC STEM CELL TRANSPLANTATION 1 0.0063
77 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 47 0.0063
78 FUNGAL SEPSIS 5 0.0060
79 ACUTE MACULAR NEURORETINOPATHY 1 0.0058
80 INTERLEUKIN-2 RECEPTOR INCREASED 1 0.0058
81 SOFT TISSUE SARCOMA 2 0.0057
82 HYPOTHALAMO-PITUITARY DISORDER 8 0.0055
83 HUMAN RHINOVIRUS TEST POSITIVE 2 0.0054
84 CHEST TUBE INSERTION 1 0.0053
85 MENINGOCOCCAL SEPSIS 1 0.0053
86 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 2 0.0053
87 CYTOMEGALOVIRUS INFECTION REACTIVATION 23 0.0052
88 BONE SARCOMA 1 0.0052
89 CENTRAL NERVOUS SYSTEM LEUKAEMIA 2 0.0051
90 OROPHARYNGEAL CANCER 1 0.0048
91 GEOTRICHUM INFECTION 1 0.0047
92 CLOSTRIDIUM BACTERAEMIA 1 0.0047
93 UPPER MOTOR NEURONE LESION 1 0.0045
94 SERUM FERRITIN INCREASED 24 0.0045
95 MYELOPROLIFERATIVE NEOPLASM 3 0.0045
96 MYELODYSPLASTIC SYNDROME 65 0.0045
97 EPILEPTIC ENCEPHALOPATHY 1 0.0045
98 SHUNT INFECTION 1 0.0044
99 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 1 0.0043
100 CEREBRAL HYPOPERFUSION 2 0.0043
101 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 1 0.0042
102 PILONIDAL DISEASE 1 0.0042
103 BLOOD URIC ACID DECREASED 2 0.0041
104 B-CELL TYPE ACUTE LEUKAEMIA 3 0.0041
105 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 1 0.0041
106 ANGIOCENTRIC LYMPHOMA 2 0.0041
107 DYSCALCULIA 1 0.0040
108 VITAMIN B1 DECREASED 1 0.0040
109 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 1 0.0039
110 ENTEROCOCCAL BACTERAEMIA 4 0.0038
111 SINUSITIS FUNGAL 3 0.0037
112 LIMBIC ENCEPHALITIS 1 0.0036
113 REPETITIVE SPEECH 2 0.0036
114 METASTASES TO MENINGES 8 0.0035
115 BLOOD FIBRINOGEN DECREASED 4 0.0035
116 HAEMATOMA INFECTION 2 0.0035
117 POSTURAL TREMOR 1 0.0034
118 FUNGAL ENDOCARDITIS 1 0.0033
119 ALANINE AMINOTRANSFERASE ABNORMAL 7 0.0033
120 PARAINFLUENZAE VIRUS INFECTION 5 0.0033
121 ACUTE LYMPHOCYTIC LEUKAEMIA 9 0.0032
122 FUNGAEMIA 5 0.0032
123 PHYSICAL DECONDITIONING 8 0.0031
124 CENTRAL HYPOTHYROIDISM 1 0.0030
125 TUMOUR FLARE 2 0.0029
126 CHOLANGITIS SCLEROSING 6 0.0029
127 NEUROENDOCRINE CARCINOMA 2 0.0029
128 BASAL CELL CARCINOMA 45 0.0029
129 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 1 0.0029
130 ANOXIA 1 0.0028
131 CHYLOTHORAX 2 0.0028
132 TIME PERCEPTION ALTERED 1 0.0028
133 CEREBRAL MASS EFFECT 1 0.0028
134 MIXED ANXIETY AND DEPRESSIVE DISORDER 1 0.0027
135 MUCORMYCOSIS 7 0.0027
136 HERPES SIMPLEX REACTIVATION 1 0.0026
137 SQUAMOUS CELL CARCINOMA OF LUNG 2 0.0026
138 LOWER RESPIRATORY TRACT INFECTION FUNGAL 1 0.0026
139 METASTATIC LYMPHOMA 1 0.0026
140 DISSEMINATED MUCORMYCOSIS 1 0.0025
141 CYTOPENIA 31 0.0025
142 DEPENDENCE ON RESPIRATOR 1 0.0025
143 TONSIL CANCER 2 0.0025
144 TRANSPLANTATION COMPLICATION 1 0.0024
145 BLOOD PRODUCT TRANSFUSION DEPENDENT 1 0.0024
146 PERIPHERAL ARTERY ANEURYSM 1 0.0024
147 MALIGNANT PLEURAL EFFUSION 4 0.0024
148 POLYSEROSITIS 1 0.0023
149 URINARY TRACT INFECTION STAPHYLOCOCCAL 1 0.0023
150 SARCOPENIA 1 0.0023
151 VASOCONSTRICTION 2 0.0023
152 ENCEPHALITIS CYTOMEGALOVIRUS 1 0.0023
153 HYPOGAMMAGLOBULINAEMIA 15 0.0023
154 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 5 0.0023
155 FACIAL NERVE DISORDER 1 0.0023
156 MENINGOENCEPHALITIS HERPETIC 1 0.0022
157 PERINEAL ABSCESS 1 0.0022
158 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
159 ENCEPHALOPATHY 53 0.0022
160 PANCREATITIS HAEMORRHAGIC 1 0.0022
161 DISSEMINATED ASPERGILLOSIS 1 0.0021
162 SARS-COV-2 ANTIBODY TEST NEGATIVE 1 0.0021
163 BLAST CELLS PRESENT 1 0.0021
164 STEROID WITHDRAWAL SYNDROME 2 0.0020
165 PERIORBITAL CELLULITIS 1 0.0019
166 BACTERIAL SEPSIS 6 0.0018
167 GASTROENTERITIS ESCHERICHIA COLI 1 0.0018
168 OXYGEN THERAPY 3 0.0018
169 DYSGRAPHIA 12 0.0018
170 INTERLEUKIN LEVEL INCREASED 1 0.0018
171 CYTOMEGALOVIRUS VIRAEMIA 8 0.0018
172 BRAIN SCAN ABNORMAL 1 0.0018
173 INFECTION REACTIVATION 2 0.0017
174 CENTRAL NERVOUS SYSTEM INFECTION 2 0.0017
175 PLEOCYTOSIS 1 0.0017
176 SYSTEMIC MYCOSIS 2 0.0017
177 ESCHERICHIA BACTERAEMIA 4 0.0017
178 PNEUMOCOCCAL INFECTION 1 0.0017
179 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
180 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
181 LYMPHATIC DISORDER 1 0.0017
182 AGRAPHIA 1 0.0017
183 PNEUMOCYSTIS JIROVECII INFECTION 2 0.0017
184 URINARY TRACT INFECTION PSEUDOMONAL 1 0.0017
185 BRAIN OEDEMA 21 0.0017
186 SECONDARY IMMUNODEFICIENCY 2 0.0016
187 SOFT TISSUE INFECTION 3 0.0016
188 HUMAN HERPESVIRUS 6 INFECTION 3 0.0016
189 HYPERCHLORAEMIA 1 0.0016
190 RESTING TREMOR 1 0.0015
191 VASCULAR DEVICE INFECTION 7 0.0015
192 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
193 FASCIITIS 1 0.0015
194 APHASIA 45 0.0015
195 TUMOUR LYSIS SYNDROME 13 0.0015
196 MARROW HYPERPLASIA 1 0.0015
197 CENTRAL NERVOUS SYSTEM LYMPHOMA 2 0.0015
198 FUSARIUM INFECTION 1 0.0014
199 FLUID IMBALANCE 1 0.0014
200 NEUTROPENIC SEPSIS 10 0.0014
201 BLADDER TRANSITIONAL CELL CARCINOMA 2 0.0014
202 PERFORATED ULCER 1 0.0013
203 MYOPERICARDITIS 1 0.0013
204 CRITICAL ILLNESS 1 0.0013
205 FEBRILE NEUTROPENIA 85 0.0013
206 MULTIPLE ORGAN DYSFUNCTION SYNDROME 36 0.0013
207 VITAMIN B12 INCREASED 1 0.0013
208 OXYGEN CONSUMPTION INCREASED 3 0.0013
209 HAEMOPERITONEUM 1 0.0012
210 PERFORATION 1 0.0012
211 HYPOXIA 43 0.0012
212 SPLENIC RUPTURE 2 0.0012
213 HYPERVOLAEMIA 6 0.0012
214 SYSTEMIC CANDIDA 3 0.0012
215 BACTERAEMIA 14 0.0012
216 FEBRILE BONE MARROW APLASIA 5 0.0012
217 HYPERBILIRUBINAEMIA 12 0.0012
218 INTESTINAL PERFORATION 13 0.0012
219 PULMONARY CAVITATION 1 0.0011
220 INTESTINAL PSEUDO-OBSTRUCTION 1 0.0011
221 HYPERLEUKOCYTOSIS 1 0.0011
222 CANDIDA SEPSIS 1 0.0011
223 SINUS NODE DYSFUNCTION 2 0.0011
224 ACUTE MYELOID LEUKAEMIA 17 0.0011
225 PNEUMONIA KLEBSIELLA 2 0.0011
226 PNEUMOPERITONEUM 2 0.0011
227 INTRACRANIAL MASS 1 0.0011
228 KLEBSIELLA BACTERAEMIA 1 0.0011
229 NEUROLOGICAL SYMPTOM 6 0.0010
230 NEUTROPENIC INFECTION 1 0.0010
231 ACTINOMYCOSIS 1 0.0010
232 ESCHERICHIA SEPSIS 3 0.0010
233 HYPOALBUMINAEMIA 8 0.0010
234 RHINOVIRUS INFECTION 4 0.0010
235 DEVICE RELATED THROMBOSIS 1 0.0010
236 BLOOD CULTURE POSITIVE 3 0.0010
237 DUODENAL ULCER 7 0.0010
238 AUTONOMIC NEUROPATHY 1 0.0010
239 PANCYTOPENIA 55 0.0010
240 HYPERURICAEMIA 4 0.0010
241 DISEASE PROGRESSION 115 0.0010
242 DIVERTICULAR PERFORATION 2 0.0010
243 NEUTROPENIC COLITIS 2 0.0010
244 POSTICTAL STATE 1 0.0010
245 SUBILEUS 2 0.0010
246 LYMPHANGIOSIS CARCINOMATOSA 1 0.0010
247 TACHYPNOEA 13 0.0010
248 BLAST CELL COUNT INCREASED 1 0.0010
249 CYTOGENETIC ANALYSIS ABNORMAL 1 0.0010
250 POLYOMAVIRUS VIRAEMIA 1 0.0009
251 SINUS BRADYCARDIA 9 0.0009
252 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
253 STREPTOCOCCAL BACTERAEMIA 1 0.0009
254 HAEMODYNAMIC INSTABILITY 7 0.0009
255 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
256 RETROPERITONEAL HAEMATOMA 2 0.0009
257 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
258 HAEMOLYTIC ANAEMIA 8 0.0009
259 KLEBSIELLA SEPSIS 1 0.0009
260 SARCOMA 1 0.0009
261 GASTROINTESTINAL CARCINOMA 8 0.0009
262 PUPILS UNEQUAL 1 0.0009
263 PANCREATITIS NECROTISING 2 0.0009
264 NEUROLOGICAL DECOMPENSATION 2 0.0009
265 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
266 PROCALCITONIN INCREASED 1 0.0009
267 HYPORESPONSIVE TO STIMULI 1 0.0009
268 INCONTINENCE 9 0.0009
269 FEBRILE INFECTION 1 0.0008
270 TRANSPLANT 2 0.0008
271 LACUNAR INFARCTION 2 0.0008
272 ESCHERICHIA TEST POSITIVE 1 0.0008
273 HAEMATOMA MUSCLE 1 0.0008
274 CARDIAC DEATH 1 0.0008
275 PHARYNGEAL HAEMORRHAGE 1 0.0008
276 HYPERNATRAEMIA 4 0.0008
277 STEM CELL TRANSPLANT 2 0.0008
278 MENTAL STATUS CHANGES 22 0.0008
279 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
280 DELIRIUM 27 0.0008
281 PLATELET TRANSFUSION 1 0.0008
282 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
283 TRANSITIONAL CELL CARCINOMA 1 0.0008
284 ADJUSTMENT DISORDER 1 0.0008
285 FOLLICULITIS 8 0.0008
286 PNEUMONIA FUNGAL 3 0.0008
287 TUMOUR PAIN 1 0.0008
288 RADICULOPATHY 2 0.0008
289 AZOTAEMIA 3 0.0008
290 VULVOVAGINAL CANDIDIASIS 1 0.0007
291 HAEMATOTOXICITY 7 0.0007
292 RECURRENT CANCER 3 0.0007
293 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 1 0.0007
294 CARDIOVERSION 1 0.0007
295 ENDOTRACHEAL INTUBATION 2 0.0007
296 MYELITIS TRANSVERSE 1 0.0007
297 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
298 STATUS EPILEPTICUS 8 0.0007
299 NEUROENDOCRINE TUMOUR 1 0.0007
300 CEREBELLAR HAEMORRHAGE 1 0.0007
301 TRACHEOSTOMY 1 0.0007
302 PELVIC VENOUS THROMBOSIS 1 0.0007
303 INVESTIGATION ABNORMAL 1 0.0007
304 GRAFT VERSUS HOST DISEASE 5 0.0007
305 PARAPLEGIA 2 0.0007
306 ENTEROCOLITIS 4 0.0007
307 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
308 MUTISM 1 0.0007
309 PANCREATIC ENZYMES INCREASED 1 0.0007
310 CARDIAC FIBRILLATION 1 0.0007
311 COVID-19 PNEUMONIA 8 0.0007
312 BRAIN HERNIATION 2 0.0007
313 STEROID DIABETES 1 0.0007
314 SUPERINFECTION 1 0.0007
315 HYPERCAPNIA 2 0.0007
316 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
317 ACIDOSIS 5 0.0007
318 PALLIATIVE CARE 1 0.0007
319 BRAIN DEATH 2 0.0006
320 MYELITIS 1 0.0006
321 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
322 CARDIAC TAMPONADE 3 0.0006
323 SEPTIC SHOCK 27 0.0006
324 QUADRIPARESIS 1 0.0006
325 CYTOMEGALOVIRUS INFECTION 10 0.0006
326 MALIGNANT MELANOMA 8 0.0006
327 ENTEROBACTER INFECTION 1 0.0006
328 KLEBSIELLA INFECTION 3 0.0006
329 HEPATORENAL SYNDROME 1 0.0006
330 CLOSTRIDIAL INFECTION 2 0.0006
331 BONE MARROW FAILURE 12 0.0006
332 SEIZURE LIKE PHENOMENA 1 0.0006
333 ENDOCARDITIS 3 0.0006
334 CEREBRAL ISCHAEMIA 3 0.0006
335 DEPRESSED LEVEL OF CONSCIOUSNESS 23 0.0006
336 SERUM FERRITIN DECREASED 1 0.0006
337 TREATMENT DELAYED 1 0.0006
338 TACHYCARDIA 51 0.0006
339 EXTREMITY NECROSIS 1 0.0006
340 PSEUDOMONAL SEPSIS 1 0.0006
341 BLOOD LACTIC ACID INCREASED 3 0.0006
342 SPINAL OSTEOARTHRITIS 5 0.0006
343 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
344 NECROTISING FASCIITIS 2 0.0006
345 LYMPHOCYTE COUNT DECREASED 10 0.0006
346 TERMINAL INSOMNIA 1 0.0006
347 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
348 CEREBRAL VENOUS THROMBOSIS 1 0.0006
349 HYPOTENSION 110 0.0005
350 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
351 CEREBRAL DISORDER 4 0.0005
352 CATHETER PLACEMENT 1 0.0005
353 SMALL INTESTINAL PERFORATION 1 0.0005
354 BONE MARROW TRANSPLANT 1 0.0005
355 MECHANICAL VENTILATION 1 0.0005
356 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
357 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
358 LYMPHOMA 8 0.0005
359 ATELECTASIS 5 0.0005
360 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
361 EARLY SATIETY 1 0.0005
362 CARDIOPULMONARY FAILURE 2 0.0005
363 THERAPY PARTIAL RESPONDER 8 0.0005
364 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
365 ABDOMINAL WALL HAEMATOMA 1 0.0005
366 DIPLEGIA 1 0.0005
367 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
368 UNRESPONSIVE TO STIMULI 13 0.0005
369 EMPYEMA 1 0.0005
370 QUADRIPLEGIA 1 0.0005
371 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
372 SHOCK 11 0.0005
373 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
374 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
375 FACIAL PARALYSIS 4 0.0005
376 LYMPHOCYTOSIS 1 0.0005
377 ASPERGILLUS INFECTION 3 0.0005
378 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
379 CEREBELLAR SYNDROME 1 0.0005
380 ENDOMETRIAL CANCER 1 0.0005
381 BLOOD CREATINE INCREASED 2 0.0005
382 URINARY RETENTION 15 0.0004
383 PARESIS 1 0.0004
384 LARGE INTESTINAL OBSTRUCTION 1 0.0004
385 DISEASE COMPLICATION 2 0.0004
386 NEOPLASM 5 0.0004
387 HYPERTRANSAMINASAEMIA 3 0.0004
388 AGRANULOCYTOSIS 8 0.0004
389 HEPATIC ENCEPHALOPATHY 4 0.0004
390 PULSE ABSENT 2 0.0004
391 WEIGHT ABNORMAL 1 0.0004
392 ACUTE RESPIRATORY FAILURE 8 0.0004
393 ASPARTATE AMINOTRANSFERASE INCREASED 22 0.0004
394 ENTEROCOCCAL INFECTION 2 0.0004
395 GUILLAIN-BARRE SYNDROME 2 0.0004
396 HEMIPARESIS 7 0.0004
397 NEUTROPENIA 56 0.0004
398 INFUSION RELATED REACTION 27 0.0004
399 RETROPERITONEAL HAEMORRHAGE 1 0.0004
400 CONFUSIONAL STATE 65 0.0004
401 VENOOCCLUSIVE DISEASE 1 0.0004
402 PLATELET DISORDER 1 0.0004
403 RETINAL ARTERY OCCLUSION 1 0.0004
404 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
405 HAEMORRHAGE URINARY TRACT 1 0.0004
406 ISCHAEMIC STROKE 7 0.0004
407 ANGLE CLOSURE GLAUCOMA 1 0.0004
408 TRISMUS 2 0.0004
409 INFECTION 56 0.0004
410 APNOEA 3 0.0004
411 ACTINIC KERATOSIS 1 0.0004
412 FAILURE TO THRIVE 2 0.0004
413 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
414 LUNG OPACITY 1 0.0004
415 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
416 SEPSIS 41 0.0004
417 ABNORMAL FAECES 3 0.0004
418 CLONUS 1 0.0004
419 ORAL FUNGAL INFECTION 1 0.0004
420 ESCHERICHIA INFECTION 3 0.0004
421 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
422 SECOND PRIMARY MALIGNANCY 3 0.0004
423 INTRACRANIAL PRESSURE INCREASED 2 0.0004
424 PYREXIA 124 0.0004
425 C-REACTIVE PROTEIN INCREASED 13 0.0004
426 CEREBRAL THROMBOSIS 1 0.0004
427 NERVOUS SYSTEM DISORDER 11 0.0004
428 HAEMOTHORAX 1 0.0003
429 HYPERKALAEMIA 12 0.0003
430 HYPONATRAEMIA 19 0.0003
431 ODYNOPHAGIA 2 0.0003
432 ATYPICAL PNEUMONIA 1 0.0003
433 PLATELET COUNT ABNORMAL 2 0.0003
434 PLEURAL EFFUSION 20 0.0003
435 DISORIENTATION 13 0.0003
436 DYSAESTHESIA 1 0.0003
437 COGNITIVE DISORDER 15 0.0003
438 ACUTE KIDNEY INJURY 49 0.0003
439 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
440 SQUAMOUS CELL CARCINOMA 3 0.0003
441 RESPIRATORY FAILURE 23 0.0003
442 PNEUMONIA VIRAL 1 0.0003
443 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
444 TREMOR 52 0.0003
445 AGITATION 23 0.0003
446 STUPOR 1 0.0003
447 THROMBOTIC MICROANGIOPATHY 3 0.0003
448 HERPES SIMPLEX 2 0.0003
449 BRADYPHRENIA 2 0.0003
450 CORONAVIRUS INFECTION 2 0.0003
451 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
452 CEREBRAL HAEMATOMA 1 0.0003
453 METASTASES TO SPINE 1 0.0003
454 CANDIDA INFECTION 5 0.0003
455 THROMBOCYTOPENIA 33 0.0003
456 NEOPLASM RECURRENCE 1 0.0003
457 NEUTROPHIL COUNT DECREASED 12 0.0003
458 B-CELL LYMPHOMA 1 0.0003
459 MOTOR DYSFUNCTION 3 0.0003
460 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
461 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
462 WOUND COMPLICATION 1 0.0003
463 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
464 APLASIA PURE RED CELL 1 0.0003
465 DROOLING 2 0.0003
466 ENCEPHALITIS 2 0.0003
467 GRANULOMA 1 0.0003
468 HYPOPNOEA 1 0.0003
469 LYMPHOPENIA 4 0.0003
470 FACIAL PARESIS 1 0.0003
471 PNEUMONIA ASPIRATION 7 0.0003
472 FACIAL BONES FRACTURE 1 0.0003
473 SEIZURE 32 0.0003
474 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
475 ARTHROPOD BITE 2 0.0003
476 LEUKOENCEPHALOPATHY 1 0.0003
477 MALNUTRITION 3 0.0003
478 CHEMOTHERAPY 1 0.0003
479 COLITIS 10 0.0003
480 HAEMATURIA 9 0.0003
481 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
482 COMMUNICATION DISORDER 1 0.0003
483 GINGIVAL DISORDER 1 0.0003
484 DEATH 224 0.0003
485 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
486 PULMONARY HAEMORRHAGE 2 0.0003
487 CEREBRAL ATROPHY 1 0.0003
488 MUSCLE HAEMORRHAGE 1 0.0002
489 MENTAL IMPAIRMENT 6 0.0002
490 BRADYCARDIA 13 0.0002
491 BODY TEMPERATURE INCREASED 5 0.0002
492 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
493 VENTRICULAR TACHYCARDIA 4 0.0002
494 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
495 ILEUS 3 0.0002
496 GASTROINTESTINAL PERFORATION 1 0.0002
497 COAGULOPATHY 4 0.0002
498 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
499 HYPERPYREXIA 1 0.0002
500 ABSCESS LIMB 1 0.0002
501 PRODUCT CONTAINER ISSUE 2 0.0002
502 PSEUDOMONAS INFECTION 2 0.0002
503 TOOTH INJURY 1 0.0002
504 MUCOSAL INFLAMMATION 6 0.0002
505 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
506 LETHARGY 13 0.0002
507 ATRIAL FIBRILLATION 22 0.0002
508 RESPIRATORY RATE INCREASED 2 0.0002
509 CARDIOTOXICITY 2 0.0002
510 SUSPECTED OFF LABEL USE 1 0.0002
511 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
512 IMMUNE THROMBOCYTOPENIA 1 0.0002
513 ISCHAEMIA 1 0.0002
514 DIVERTICULITIS 6 0.0002
515 PERSONALITY CHANGE 2 0.0002
516 BACTERIAL INFECTION 4 0.0002
517 BLOOD SODIUM DECREASED 4 0.0002
518 LEUKAEMIA 2 0.0002
519 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
520 SUBDURAL HAEMATOMA 3 0.0002
521 HYPOVOLAEMIC SHOCK 1 0.0002
522 GASTROINTESTINAL TOXICITY 1 0.0002
523 RENAL CELL CARCINOMA 1 0.0002
524 STAPHYLOCOCCAL SEPSIS 1 0.0002
525 INFLAMMATORY MARKER INCREASED 1 0.0002
526 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
527 PLATELET COUNT DECREASED 21 0.0002
528 MEMORY IMPAIRMENT 27 0.0002
529 CHILLS 23 0.0002
530 AMMONIA INCREASED 1 0.0002
531 PARTIAL SEIZURES 1 0.0002
532 ARRHYTHMIA 9 0.0002
533 HALLUCINATION, VISUAL 4 0.0002
534 COMA 9 0.0002
535 LIVER FUNCTION TEST INCREASED 4 0.0002
536 ANAL ABSCESS 1 0.0002
537 LACTIC ACIDOSIS 6 0.0002
538 HYDROCEPHALUS 1 0.0002
539 WOUND INFECTION 2 0.0002
540 ASPIRATION 2 0.0002
541 COVID-19 32 0.0002
542 HEART RATE ABNORMAL 1 0.0002
543 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
544 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
545 PRODUCT LEAKAGE 1 0.0002
546 REBOUND EFFECT 2 0.0002
547 MYOCARDIAL ISCHAEMIA 2 0.0002
548 PERICARDIAL EFFUSION 4 0.0002
549 NEOPLASM PROGRESSION 6 0.0002
550 HYPOVOLAEMIA 1 0.0002
551 HYPERTRIGLYCERIDAEMIA 1 0.0002
552 SPLENOMEGALY 2 0.0002
553 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
554 DISEASE RECURRENCE 8 0.0002
555 CHOLECYSTITIS 2 0.0002
556 PROTHROMBIN TIME PROLONGED 1 0.0002
557 POLYNEUROPATHY 2 0.0002
558 HEPATITIS B 1 0.0002
559 HYPERGLYCAEMIA 6 0.0002
560 OLIGURIA 1 0.0002
561 THERAPY NON-RESPONDER 7 0.0002
562 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
563 MENINGITIS 1 0.0001
564 GAIT INABILITY 5 0.0001
565 POST-TRAUMATIC STRESS DISORDER 1 0.0001
566 BREAST MASS 1 0.0001
567 ULCER HAEMORRHAGE 1 0.0001
568 INFARCTION 1 0.0001
569 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
570 UNEVALUABLE EVENT 11 0.0001
571 JOINT EFFUSION 1 0.0001
572 RESPIRATORY DISTRESS 4 0.0001
573 SOMNOLENCE 29 0.0001
574 OXYGEN SATURATION DECREASED 8 0.0001
575 LYMPHADENOPATHY 5 0.0001
576 DIALYSIS 2 0.0001
577 THERMAL BURN 1 0.0001
578 RETINAL HAEMORRHAGE 1 0.0001
579 PANIC REACTION 1 0.0001
580 ASCITES 4 0.0001
581 MYALGIA 23 0.0001
582 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
583 IMMUNODEFICIENCY 2 0.0001
584 HAEMORRHAGE INTRACRANIAL 2 0.0001
585 HYDRONEPHROSIS 1 0.0001
586 HEPATIC FAILURE 4 0.0001
587 HYPERTHERMIA 1 0.0001
588 EPILEPSY 4 0.0001
589 EJECTION FRACTION DECREASED 2 0.0001
590 AFFECTIVE DISORDER 1 0.0001
591 ATRIAL FLUTTER 1 0.0001
592 SHOCK HAEMORRHAGIC 1 0.0001
593 DECUBITUS ULCER 1 0.0001
594 LUNG NEOPLASM MALIGNANT 5 0.0001
595 CARDIAC ARREST 10 0.0001
596 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
597 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
598 HEMIPLEGIA 1 0.0001
599 VIRAL INFECTION 4 0.0001
600 FUNGAL INFECTION 4 0.0001
601 CARDIO-RESPIRATORY ARREST 5 0.0001
602 ATRIAL SEPTAL DEFECT 1 0.0001
603 CIRCULATORY COLLAPSE 2 0.0001
604 DECREASED APPETITE 27 0.0001
605 MUSCULOSKELETAL DISCOMFORT 2 0.0001
606 ANURIA 1 0.0001
607 MYOPATHY 1 0.0001
608 FATIGUE 90 0.0001
609 ILL-DEFINED DISORDER 7 0.0001
610 RESPIRATORY TRACT INFECTION 3 0.0001
611 ORTHOSTATIC HYPOTENSION 2 0.0001
612 IMMUNOSUPPRESSION 1 0.0001
613 PULMONARY OEDEMA 5 0.0001
614 GASTROINTESTINAL INFECTION 1 0.0001
615 BLOOD BILIRUBIN INCREASED 3 0.0001
616 OPTIC NEURITIS 1 0.0001
617 PNEUMONIA BACTERIAL 1 0.0001
618 UROSEPSIS 1 0.0001
619 RENAL IMPAIRMENT 9 0.0001
620 APPENDICITIS 1 0.0001
621 HEPATIC CIRRHOSIS 2 0.0001
622 DYSARTHRIA 4 0.0001
623 DYSPHAGIA 10 0.0001
624 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
625 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
626 AFFECT LABILITY 1 0.0001
627 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
628 ORAL HERPES 2 0.0001
629 HEPATOMEGALY 1 0.0001
630 ACUTE MYOCARDIAL INFARCTION 3 0.0001
631 HOSPICE CARE 1 0.0001
632 HYPOTONIA 1 0.0001
633 AGGRESSION 5 0.0001
634 BRAIN INJURY 1 0.0001
635 LACRIMATION INCREASED 3 0.0001
636 FULL BLOOD COUNT DECREASED 2 0.0001
637 PERITONITIS BACTERIAL 1 0.0001
638 PRODUCT ADMINISTRATION ERROR 2 0.0001
639 HYPOTHERMIA 1 0.0001
640 FLUID RETENTION 5 0.0001
641 TRANSFUSION 1 0.0001
642 SPEECH DISORDER 5 0.0001
643 FULL BLOOD COUNT ABNORMAL 1 0.0001
644 METABOLIC ACIDOSIS 3 0.0001
645 HIP FRACTURE 3 0.0001
646 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
647 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
648 STAPHYLOCOCCAL INFECTION 3 0.0001
649 VENTRICULAR FIBRILLATION 1 0.0001
650 TYPE 2 DIABETES MELLITUS 3 0.0001
651 GASTRIC HAEMORRHAGE 1 0.0001
652 ELECTROLYTE IMBALANCE 1 0.0001
653 POST PROCEDURAL HAEMORRHAGE 1 0.0001
654 TREATMENT FAILURE 7 0.0001
655 MYOCLONUS 1 0.0001
656 CEREBRAL HAEMORRHAGE 3 0.0001
657 HYPERLIPIDAEMIA 1 0.0001
658 PNEUMONIA 27 0.0001
659 THYROID CANCER 1 0.0001
660 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
661 MALAISE 36 0.0001
662 CEREBRAL INFARCTION 2 0.0001
663 SMALL INTESTINAL OBSTRUCTION 1 0.0001
664 GENERALISED OEDEMA 1 0.0001
665 HEPATIC FUNCTION ABNORMAL 3 0.0001
666 ANAEMIA 15 0.0001
667 LOSS OF CONSCIOUSNESS 10 0.0001
668 ANAPHYLACTIC SHOCK 2 0.0001
669 INFLAMMATION 4 0.0001
670 HAEMATOMA 2 0.0001
671 DIPLOPIA 2 0.0001
672 IMMUNE SYSTEM DISORDER 1 0.0001
673 BLOOD PRESSURE DECREASED 5 0.0001
674 NEOPLASM MALIGNANT 5 0.0001
675 OEDEMA 4 0.0001
676 BLINDNESS 3 0.0001
677 ACUTE HEPATIC FAILURE 1 0.0001
678 SKIN LESION 2 0.0001
679 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
680 MASS 1 0.0001
681 SKIN REACTION 1 0.0001
682 TARDIVE DYSKINESIA 2 0.0001
683 HEPATOCELLULAR INJURY 1 0.0001
684 SINUS TACHYCARDIA 1 0.0001
685 SYNCOPE 7 0.0001
686 CARDIOGENIC SHOCK 1 0.0001
687 HYPERTHYROIDISM 1 0.0001
688 FLUID OVERLOAD 1 0.0001
689 LABORATORY TEST ABNORMAL 2 0.0001
690 CEREBROVASCULAR ACCIDENT 11 0.0001
691 EMOTIONAL DISORDER 2 0.0001
692 BRAIN FOG 1 0.0001
693 PNEUMOTHORAX 1 0.0001
694 ULCER 1 0.0001
695 CYSTITIS 2 0.0001
696 INFLUENZA 7 0.0001
697 SENSORY DISTURBANCE 1 0.0001
698 BLOOD POTASSIUM INCREASED 1 0.0001
699 LEUKOPENIA 3 0.0001
700 SKIN DISORDER 2 0.0001
701 FACE OEDEMA 1 0.0001
702 BALANCE DISORDER 5 0.0001
703 HEAD DISCOMFORT 1 0.0001
704 DRUG ERUPTION 1 0.0001
705 GASTROINTESTINAL DISORDER 5 0.0001
706 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
707 MYELOSUPPRESSION 2 0.0001
708 HEADACHE 34 0.0001
709 THINKING ABNORMAL 1 0.0001
710 HYPOCALCAEMIA 1 0.0001
711 MUSCULAR WEAKNESS 6 0.0001
712 RENAL FAILURE 7 0.0001
713 PULMONARY FIBROSIS 1 0.0001
714 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
715 POST PROCEDURAL COMPLICATION 1 0.0001
716 HYPERTENSION 11 0.0001
717 ASTHENIA 19 0.0001
718 SINUS DISORDER 1 0.0001
719 CARDIAC FAILURE 4 0.0000
720 HAEMOGLOBIN DECREASED 5 0.0000
721 PRODUCT PREPARATION ERROR 1 0.0000
722 PERITONITIS 1 0.0000
723 TOOTH LOSS 1 0.0000
724 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
725 GAIT DISTURBANCE 9 0.0000
726 RETCHING 1 0.0000
727 HYPOACUSIS 2 0.0000
728 SKIN CANCER 1 0.0000
729 DEEP VEIN THROMBOSIS 3 0.0000
730 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
731 PRODUCT PRESCRIBING ISSUE 1 0.0000
732 MELAENA 1 0.0000
733 STEVENS-JOHNSON SYNDROME 1 0.0000
734 TRANSAMINASES INCREASED 1 0.0000
735 TOOTH DISORDER 1 0.0000
736 HEPATOTOXICITY 1 0.0000
737 ORAL PAIN 1 0.0000
738 PARAESTHESIA 7 0.0000
739 HEART RATE IRREGULAR 1 0.0000
740 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
741 DRUG INEFFECTIVE 57 0.0000
742 RENAL DISORDER 2 0.0000
743 PULMONARY EMBOLISM 4 0.0000
744 PRESYNCOPE 1 0.0000
745 NEURALGIA 1 0.0000
746 LUNG DISORDER 2 0.0000
747 LIVER INJURY 1 0.0000
748 DIARRHOEA 26 0.0000
749 CELLULITIS 2 0.0000
750 ABDOMINAL PAIN LOWER 1 0.0000
751 GASTRIC CANCER 1 0.0000
752 PRODUCT COMPLAINT 1 0.0000
753 CARDIOVASCULAR DISORDER 1 0.0000
754 HYPOPHAGIA 1 0.0000
755 DRUG RESISTANCE 1 0.0000
756 ILLNESS 4 0.0000
757 SEDATION 1 0.0000
758 JAUNDICE 1 0.0000
759 DYSPNOEA 21 0.0000
760 LIMB INJURY 1 0.0000
761 PALLOR 1 0.0000
762 NAUSEA 29 0.0000
763 DEMENTIA 1 0.0000
764 COUGH 10 0.0000
765 TOXICITY TO VARIOUS AGENTS 6 0.0000
766 EYE PAIN 2 0.0000
767 PAIN IN JAW 1 0.0000
768 URINARY TRACT INFECTION 6 0.0000
769 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
770 RED BLOOD CELL COUNT DECREASED 1 0.0000
771 HYPERSOMNIA 1 0.0000
772 LIVER FUNCTION TEST ABNORMAL 1 0.0000
773 OFF LABEL USE 30 0.0000
774 VOMITING 16 0.0000
775 URINARY INCONTINENCE 1 0.0000
776 IRRITABILITY 2 0.0000
777 STOMATITIS 2 0.0000
778 DISCOMFORT 2 0.0000
779 CHEST PAIN 6 0.0000
780 HEAD INJURY 1 0.0000
781 NEUROPATHY PERIPHERAL 3 0.0000
782 MOOD SWINGS 1 0.0000
783 ARTHRALGIA 13 0.0000
784 MOVEMENT DISORDER 1 0.0000
785 NIGHT SWEATS 1 0.0000
786 HEART RATE INCREASED 3 0.0000
787 LIP SWELLING 1 0.0000
788 CONDITION AGGRAVATED 9 0.0000
789 HEPATIC ENZYME INCREASED 2 0.0000
790 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
791 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
792 ABDOMINAL DISTENSION 3 0.0000
793 HEART RATE DECREASED 1 0.0000
794 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
795 RESTLESSNESS 1 0.0000
796 DYSURIA 1 0.0000
797 ABNORMAL BEHAVIOUR 1 0.0000
798 WEIGHT DECREASED 7 0.0000
799 PROSTATE CANCER 2 0.0000
800 DEVICE BREAKAGE 1 0.0000
801 OEDEMA PERIPHERAL 3 0.0000
802 FALL 8 0.0000
803 DEVICE LEAKAGE 1 0.0000
804 ANGIOEDEMA 1 0.0000
805 LIVER DISORDER 1 0.0000
806 DEHYDRATION 3 0.0000
807 COLITIS ULCERATIVE 1 0.0000
808 THROAT IRRITATION 1 0.0000
809 TINNITUS 1 0.0000
810 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
811 SWELLING 2 0.0000
812 COLORECTAL CANCER 1 0.0000
813 INTERSTITIAL LUNG DISEASE 1 0.0000
814 RASH 9 0.0000
815 FLUSHING 2 0.0000
816 THERAPY CESSATION 1 0.0000
817 DEPRESSED MOOD 1 0.0000
818 RASH PRURITIC 1 0.0000
819 CONSTIPATION 4 0.0000
820 ANAPHYLACTIC REACTION 1 0.0000
821 MEDICATION ERROR 1 0.0000
822 FLATULENCE 1 0.0000
823 HERPES ZOSTER 1 0.0000
824 MYOCARDIAL INFARCTION 3 0.0000
825 BONE PAIN 1 0.0000
826 SURGERY 1 0.0000
827 BLADDER CANCER 1 0.0000
828 VERTIGO 1 0.0000
829 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
830 VISUAL IMPAIRMENT 2 0.0000
831 INTENTIONAL OVERDOSE 1 0.0000
832 AMNESIA 1 0.0000
833 ABDOMINAL PAIN UPPER 3 0.0000
834 ANXIETY 4 0.0000
835 THERAPY INTERRUPTED 1 0.0000
836 MOBILITY DECREASED 1 0.0000
837 PAIN IN EXTREMITY 4 0.0000
838 EPISTAXIS 1 0.0000
839 HYPOAESTHESIA 2 0.0000
840 HALLUCINATION 1 0.0000
841 DEPRESSION 3 0.0000
842 INCORRECT DOSE ADMINISTERED 3 0.0000
843 PERIPHERAL SWELLING 2 0.0000
844 BACK PAIN 3 0.0000
845 CARDIAC FAILURE CONGESTIVE 1 0.0000
846 THROMBOSIS 1 0.0000
847 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
848 INFLUENZA LIKE ILLNESS 1 0.0000
849 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
850 SUICIDAL IDEATION 1 0.0000
851 ADVERSE EVENT 1 0.0000
852 NASOPHARYNGITIS 2 0.0000
853 BREAST CANCER 1 0.0000
854 CARDIAC DISORDER 1 0.0000
855 BLOOD GLUCOSE INCREASED 2 0.0000
856 CONTUSION 1 0.0000
857 DRUG INTOLERANCE 1 0.0000
858 SINUSITIS 1 0.0000
859 HAEMORRHAGE 1 0.0000
860 ABDOMINAL PAIN 2 0.0000
861 FEELING ABNORMAL 2 0.0000
862 JOINT SWELLING 1 0.0000
863 PAIN 5 0.0000
864 HYPERHIDROSIS 1 0.0000
865 VISION BLURRED 1 0.0000
866 BLOOD PRESSURE INCREASED 1 0.0000
867 DIZZINESS 3 0.0000
868 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
869 NO ADVERSE EVENT 1 0.0000
870 MUSCLE SPASMS 1 0.0000
871 HYPERSENSITIVITY 1 0.0000
872 PRODUCT USE ISSUE 1 0.0000
873 PRURITUS 2 0.0000
874 ALOPECIA 1 0.0000
875 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
876 ERYTHEMA 1 0.0000